Enhanced Efficacy of Combined Iliac Crest Bone Graft and Recombinant Human Bone Morphogenetic Protein for Alveolar Bone Grafting
Artur Manasyan, Idean Roohani, Caroline Kreh, Anika Kim, Meryem Guler, Joseph Firriolo, Laura Herrera, Marvee Turk, William P. Magee, Mark M. Urata, Jeffrey A. HammoudehBackground
This study compares clinical and radiographic outcomes in alveolar bone grafting (ABG) using iliac crest bone graft (ICBG) alone, demineralized bone matrix (DBM) with recombinant human bone morphogenetic protein-2 (rhBMP-2), and ICBG with recombinant human bone morphogenetic protein-2 with demineralized bone matrix (rhBMP2/DBM).
Purpose
We evaluated differences in clinical success and radiographic bone formation among grafting techniques for secondary alveolar cleft repair.
Study Design, Setting, and Sample
Retrospective cohort study of patients undergoing secondary ABG for cleft alveolus between 2017 and 2023 at a tertiary children's hospital.
Independent Variable
Type of grafting technique: ICBG alone, DBM with rhBMP-2, or ICBG with rhBMP-2.
Main Outcome Variables
The primary outcome was radiographic success (bony bridging on cone-beam computed tomography). Secondary outcomes included vertical bone height and reoperation.
Covariates
Age, sex, cleft laterality, and graft type.
Analyses
Descriptive statistics and comparative analyses were performed. Statistical significance was set at
Results
A total of 432 patients (527 clefts) were included: 196 ICBG, 284 DBM + rhBMP-2, and 47 ICBG + rhBMP-2. Radiographic success was highest in the ICBG + rhBMP-2 group (89.4%) compared with ICBG (65.3%;
Conclusions and Relevance
ICBG combined with rhBMP-2 demonstrates improved radiographic bone formation and vertical height compared with alternative grafting strategies, without increasing reoperation rates.